'Clear Quid Pro Quo': HHS Jeers Big Pharma's Kickback Salvo
A pharmaceutical industry proposal to subsidize the use of taxpayer-funded drugs "clearly involves quid pro quo exchanges" that the industry itself says are legally problematic, federal health care officials said Tuesday,...To view the full article, register now.
Already a subscriber? Click here to view full article